Amundi Asset Management US
ISEE

Amundi Asset Management US’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Amundi Asset Management US’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-86,992
Closed -$4.01M – 562
2016
Q3 		$4.01M Buy
86,992
+23,005
+36% +$1.3M 0.01% 441
2016
Q2 		$3.27M Sell
63,987
-105
-0.2% -$5.22K 0.01% 464
2016
Q1 		$2.71M Sell
64,092
-19,076
-23% -$972K 0.01% 474
2015
Q4 		$6.53M Sell
83,168
-44,702
-35% -$2.58M 0.02% 385
2015
Q3 		$5.18M Buy
+127,870
New +$6.77M 0.02% 421

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Asset Management US's ISEE Position: Q4 2016 in Review

Amundi Asset Management US sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 86,992 shares — an estimated $4.01M sold.

Amundi Asset Management US first reported a position in ISEE in Q3 2015 and held it in 5 quarters. The position peaked at $6.53M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Amundi Asset Management US reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Amundi Asset Management US sold 86,992 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $4.01M.
  • Amundi Asset Management US first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
  • Amundi Asset Management US's IVERIC bio, Inc. Common Stock position peaked at $6.53M in Q4 2015.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Amundi Asset Management US's 13F filing for Q4 2016, filed 9 Feb 2017.